business enterprise
Electronic Genome Mapping Entered a Blood-Cancer Collaboration
Nabsys and Indiana University began a multiyear effort to evaluate the platform for hematologic malignancies.
Summary
Nabsys and Indiana University began a multiyear effort to evaluate the platform for hematologic malignancies.
Nabsys announced a multiyear research collaboration with Indiana University to develop and evaluate electronic genome mapping applications in hematologic malignancies. The method is intended to resolve structural variation electronically. This is a company-announced research agreement and platform-development program; it is not a clinical performance result, regulatory clearance or demonstrated patient benefit.
Why it matters
Nabsys and Indiana University began a multiyear effort to evaluate the platform for hematologic malignancies.
Limits and context
- This is a company-announced research agreement and platform-development program; it is not a clinical performance result, regulatory clearance or demonstrated patient benefit.
Key claims
Nabsys and Indiana University began a multiyear effort to evaluate the platform for hematologic malignancies.
Qualification: This is a company-announced research agreement and platform-development program; it is not a clinical performance result, regulatory clearance or demonstrated patient benefit.
Evidence: source-2026-08-01-013
Sources
- Nabsys via Newswise: Indiana University electronic genome mapping collaborationNabsys via Newswise · official announcement
Corrections
No corrections have been recorded for this story.